2nd International Conference on

Vaccine Research and Development

April 22-24, 2024 | Holiday Inn Munich South, Munich, Germany

  • Authors are invited to submit abstracts through the Conference Submission Systems, Click the Submit Abstract Button Below.

Submit Abstract Register Now

Conference Chair

chair-image

Dr. De Chu Christopher Tang

CEO of VaxDome Inc
USA

Title of Talk:

Virus/Mutation-Agnostic Vaccines

Conference Co-Chair

chair-image

Chil-Yong Kang

University of Western Ontario,
Canada

Title of The Talk:

Research and Development of Vaccines for
Future Pandemic Preparedness

Exhibitors

Description: CTL is the only company that specializes on GLP compliant high throughput ELISPOT analysis for monitoring T cell immunity in clinical trials (CRO).CTL is the leading manufacturer of ELISPOT analyzers, reagents required for ELISPOT standardization, including reference PBMCs, up to 4 color ImmunoSpot® ELISPOT T and B Cell Kits and Serum-Free-Media.

Subscribe for timely updates on international conferences, workshops, and more. Our platform isn't just about upcoming conferences; it's also your comprehensive event promotion portal where you can list your conference easily. Benefit from free indexing and connect with a global audience at your fingertips.. Discover a world of opportunities and enhance your career. Don't miss out. Empower your journey with All Conference Alert. Subscribe today!

Scientific Board

Aim

Our aim to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Vaccine Research and Development.

Objective

To provide a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent solutions adopted in the fields of Vaccine Research and Development.

Dates to remember

Abstract Submission Deadline
February 28, 2024
Early Bird Registration
October 20, 2023
Conference Dates
April 22-24, 2024

Welcome Message by Conference Chair

Submit Abstract Register Now

Plenary Speakers

De-chu Christopher Tang
De-chu Christopher Tang

CEO of VaxDome Inc
USA

Barry T. Rouse
Barry T. Rouse

University of Tennessee
USA

Keith R. Jerome
Keith R. Jerome

University of Washington
USA

Julissa Soto
Julissa Soto

CEO and Founder of Julissa Soto Latino Health Equity Consulting
USA

Harry Kleanthous
Harry Kleanthous

SK Bioscience
USA

Graeme Ladds
Graeme Ladds

CEO of PharSafer
United Kingdom

Dr. Xia JIN
Dr. Xia JIN

CEO of Immuno Cure
Hong Kong

Chil-Yong  Kang
Chil-Yong Kang

University of Western Ontario
Canada

Nagy Habib
Nagy Habib

Imperial College London
United Kingdom

Xiao-Qing  Qiu
Xiao-Qing Qiu

Sichuan University
China

Michael Agrez
Michael Agrez

CEO at Inter-K
Peptide Therapeutics
Australia

Kiat Ruxrungtham
Kiat Ruxrungtham

Chulalongkorn University
Thailand

Petro Terblanche
Petro Terblanche

CEO of Afrigen Biologics
South Africa

Tomas Hanke
Tomas Hanke

University of Oxford
United Kingdom

Márcia CA Fantini
Márcia CA Fantini

University of Sao Paulo
Brazil

Keynote Speakers

Yongqun Oliver He
Yongqun Oliver He

University of Michigan
USA

Cody Wenthur
Cody Wenthur

University of Wisconsin-Madison
USA

Hossein Hosseinkhani
Hossein Hosseinkhani

Founder of Matrix Inc
USA

Aykut Ozdarendeli
Aykut Ozdarendeli

Erciyes University
Turkey

Luca Roncati
Luca Roncati

University of Modena & Reggio Emilia
Italy

 Ivana D. Lukic
Ivana D. Lukic

University of Belgrade
Serbia

Nobalanda Mokoena
Nobalanda Mokoena

Ondersterpoort Biological Products
South Africa

Essa Suleman
Essa Suleman

Council for Scientific and Industrial Research
South Africa

Huang Wei Ling
Huang Wei Ling

Medical Acupuncture and Pain Management Clinic
Brazil

Solomon I. Ubani
Solomon I. Ubani

Metropolitan University
United Kingdom

Paulo Ricardo Martins-Filho
Paulo Ricardo Martins-Filho

Federal University of Sergipe
Brazil

Kalliopi Megari
Kalliopi Megari

Aristotle University of Thessaloniki
Greece

Rami Hani Al-Rifai
Rami Hani Al-Rifai

United Arab Emirates University
United Arab Emirates

Anjula Gurtoo
Anjula Gurtoo

Indian Institute of Science
India

Invited Speakers

Greg A. Kirchenbaum
Greg A. Kirchenbaum

Cellular Technology Limited
USA

Fandan Meng
Fandan Meng

Harbin Veterinary Research Institute
China

Tongqing An
Tongqing An

Harbin Veterinary Research Institute
China

Juliana Melgaço
Juliana Melgaço

Immune Technology Laboratory
Brazil

Tatyana Costa Amorim Ramos
Tatyana Costa Amorim Ramos

Federal University of Rondônia
Brazil

Daniel A.M. Villela
Daniel A.M. Villela

Columbia University
Brazil

Daniela Alejandra Loaiza Martinez
Daniela Alejandra Loaiza Martinez

Indoamerica University
Ecuador

Lorna Galleguillos
Lorna Galleguillos

Clinica Alemana Santiago
Chile

Neveen Gerges Zaki
Neveen Gerges Zaki

Ministry of Health and Population
Egypt

Desmond MaadaKangbai
Desmond MaadaKangbai

Njala University
Sierra Leone

Rachna Chaturvedi
Rachna Chaturvedi

Amity University
India

Scientific Sessions
  • Coronavirus Disease (COVID-19)
  • Cancer, Malaria and TB Vaccines
  • Vaccine Regulation, Safety and Efficacy
  • Vaccines against Neurological Infections
  • Veterinary Vaccines
  • Nano Vaccine Technology
  • Next Generation Vaccines Delivery Technologies
  • HIV/AIDS Vaccines
  • Vaccine Storage and Handlings
  • Vaccines for Vector-Borne Diseases
  • Vaccines for Pregnant Women and Neonates
  • Hepatitis Vaccines and Liver Diseases
  • Animal and Plant Derived Vaccines
  • Infectious & Non-infectious diseases
  • New Trends in Vaccines Development
  • Vaccines Misperception and Side Effects
  • Live-Attenuates Vaccines
  • Analytical Method Life Cycle, Analytical QbD and Vaccines release testing
Scientific Sessions
  • Immunology of Infectious Diseases
  • Influenza Vaccines
  • Bioprocessing & Manufacturing of vaccines
  • Vaccine Adjuvants
  • Antimicrobials/Antibiotics/Antibacterial
  • Immuno-Pathology
  • Geriatric Immunization
  • Vaccines for Respiratory Diseases
  • Mucosal Vaccines
  • Ebola Vaccine
  • Emerging & Re-Emerging Diseases
  • Vaccine Immunology
  • Therapeutic Vaccines
  • Bacterial Diseases
  • Viral Diseases
  • Vaccines Business Development
  • Parasitic Diseases
  • Medicine and Vaccine for Covid-19

Previous Glimpses

Need help now? Mail us now: icvrd-2024@pagesconferences.com

Book your Speaker or Delegate slot. Contact us regarding group registrations on special prices

Media Partners

 All Conference Alert! Subscribe for timely updates on international conferences, workshops, and more. Our platform isn't just about upcoming conferences; it's also your comprehensive event promotion portal where you can list your conference easily. Benefit from free indexing and connect with a global audience at your fingertips.. Discover a world of opportunities and enhance your career. Don't miss out. Empower your journey with All Conference Alert. Subscribe today!

All Conference Alert

All Conference Alert! Subscribe for timely updates on international conferences, workshops, and more. Our platform isn't just about upcoming conferences; it's also your comprehensive event promotion portal where you can list your conference easily. Benefit from free indexing and connect with a global audience at your fingertips.. Discover a world of opportunities and enhance your career. Don't miss out. Empower your journey with All Conference Alert. Subscribe today!